Coller EQT related stories
All articles and analysis
Friday Letter Looking for reasons not to investLPs are reporting a record number of fundraising extension requests – and may be toughening their stance on issues like ‘key man’ clauses as they make fewer and smaller commitments.
- Friday Letter Stepping down and stepping back
Succession has long been a tricky issue to deal with for private equity firms, but several groups have demonstrated in recent weeks that it need not be a painful process.
- Friday Letter LP's want a special relationship
Separate accounts are all the rage, for good reasons
- Friday Letter Private equity to the rescue
‘Traditional’ asset classes are expected to produce lackluster returns this year, highlighting once again the importance of private equity for investors to reach their overall returns objectives.
- Study: GPs underestimated risks in Asia
Fund managers were too optimistic about China and India and especially underestimated the political risks in each country, according to an investor survey by Coller Capital.
- Permira performance boosts SVG
Strong performance across Permira’s funds has sent SVG Capital’s net asset value up 16.6% in the first quarter.
- LACERS bets on secondary market
The $10.8bn system recently committed to Coller Capital as a way to ‘diversify existing private equity portfolios, obtain exposure to previously restricted funds and participate directly in select investments’.
- Conway: Debt and Europe provide opportunities
Limited partners in private equity funds should focus more on debt investing and debt products such as CLOs, according to The Carlyle Group's Bill Conway.
- Avista hires pharma head for healthcare
The firm has added Brian Markison, former CEO of Fougera Pharmaceuticals, as an industry executive to help source deals and oversee investments. Avista now has 13 operating executives.
- Secondaries Special: Crowding the market
New entrants to the private equity secondary market are attracting talent and capital that was previously the sole preserve of dedicated secondaries investors. Graham Winfrey reports